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Edited by Hans EklundAbstract The X-ray structure of the ligand-binding core of the
kainate receptor GluR5 (GluR5-S1S2) in complex with (S)-gluta-
mate was determined to 1.95 A˚ resolution. The overall GluR5-
S1S2 structure comprises two domains and is similar to the related
AMPA receptor GluR2-S1S2J. (S)-glutamate binds as in GluR2-
S1S2J. Distinct features are observed for Ser741, which stabilizes
a highly coordinated network of water molecules and forms an
interdomain bridge. The GluR5 complex exhibits a high degree
of domain closure (26) relative to apoGluR2-S1S2J. In addition,
GluR5-S1S2 forms a novel dimer interface with a diﬀerent
arrangement of the two protomers compared to GluR2-S1S2J.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Ionotropic glutamate receptors (iGluRs) form a family of li-
gand-gated ion channels that play a central role in rapid neuro-
nal signaling in the central nervous system. The complex roles of
the iGluRs are far from being understood in detail but it is gen-
erally accepted that these receptors are implicated in a number of
psychiatric and neurological disorders such as Alzheimers, Par-
kinsons and Huntingtons diseases, schizophrenia and epilepsy
[1–3].Hence, the iGluRsare beingpursuedasobviousdrug targets.
The iGluRs are membrane-bound and form tetramers
assembled as dimers-of-dimers [4–8]. One receptor subunit is
composed of an extracellular N-terminal domain, a ligand-Abbreviations: 4-AHCP, 2-amino-3-(3-hydroxy-7,8-dihydro-6H-cyclo-
hepta[d]-4-isoxazolyl)propionate; AMPA, 2-amino-3-(3-hydroxy-5-
methyl-4-isoxazolyl)propionate; ATPA, 2-amino-3-(5-tert-butyl-3-
hydroxy-4-isoxazolyl)propionate; E. coli, Escherichia coli; EDTA,
ethylenediaminetetraacetate; GluR2-S1S2J, ligand-binding core con-
struct of GluR2; GluR5-S1S2, ligand-binding core construct of GluR5;
HEPES, N-2-hydroxyethylpiperazine-N0-2-ethanesulfonate; iGluR,
ionotropic glutamate receptor; IPTG, isopropyl-b-D-thiogalacto-
pyranoside; M1–M3, three transmembrane spanning regions; NMDA,
N-methyl-D-aspartate; NR1-S1S2, ligand-binding core construct of
NR1; r.m.s.d., root mean square deviation; PCR, polymerase chain
reaction; PEG, polyethylene glycol; vdW, van der Waals
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doi:10.1016/j.febslet.2005.01.012binding core made of segments S1 and S2 forming two do-
mains (D1 and D2), three transmembrane spanning regions
(M1–M3) and a re-entrant loop between M1 and M2 as well
as a cytoplasmic region. The current picture on iGluR function
implies a ‘‘Venus ﬂytrap’’ mechanism of the bilobular ligand-
binding core that in the resting state (without ligand bound)
is in an open form and upon binding of agonist, it adopts a
closed form with concomitant opening of the channel pore.
The extent of domain closure is correlated to the activation
and desensitization of the receptor [1,9–13].
The iGluRs have been subdivided into three heterogeneous
classes based on sequence identity and their aﬃnities for the
selective agonists 2-amino-3-(3-hydroxy-5-methyl-4-isoxa-
zolyl)propionate (AMPA), kainate and N-methyl-D-aspartate
(NMDA). A soluble construct of the ligand-binding core of
the AMPA receptor GluR2 (GluR2-S1S2J) [9] and of the
NMDA receptor NR1 [14] have previously been expressed in
Escherichia coli and both were shown to have pharmacological
binding proﬁles resembling those of the full-length receptors.
The subsequent crystallization and structure determinations of
these two constructs in complex with diﬀerent agonists
[9–11,14–16] and antagonists [9,17] have provided a wealth of
information on binding modes and mechanisms of action of
the AMPA and NMDA classes of receptors. Until now, how-
ever, this knowledge has been missing for the kainate class.
Here, we report the X-ray structure of the ligand-binding core
ofGluR5 (GluR5-S1S2) in complexwith the endogenous neuro-
transmitter (S)-glutamate. The GluR5 receptor belongs to the
kainate class of iGluRs. Hence, the present structure provides
detailed information on hitherto unknownmodes of interaction
of (S)-glutamatewith theﬁrst representativeof this classof iGluRs.2. Materials and methods
2.1. Expression and puriﬁcation
The construct for expression of the ligand-binding core of GluR5
was made as follows. The S1 and S2 segments constituting the li-
gand-binding core were polymerase chain reaction (PCR)-ampliﬁed
from full-length GluR5 using the primers: S1-forward: ATT-
TGAATTCCGTGGTGCTAACCGCACACTCATTG; S1-reverse:
ATTAGGTACCCTTCCGGTAAAGGATGC; S2-forward: ATTA-
GGTACCCCCATCGATTCCGCAGACG and S2-reverse: AATTC
TCGAGTTAAGGGCAGCCATTCCCC. PCR-products were di-
gested with restriction enzymes and ligated into pET-28a(+) (Novagen,
WI, USA) in a three-point ligation. The expressed protein contains an
N-terminal His-tag, a trypsin cleavage site and the GluR5 sequence
[430-ANRTLI. . .SILYRK-544], [667-PIDSAD. . .WRGNGC-805]
separated by a Gly-Thr linker. An N-terminal glycine in theblished by Elsevier B.V. All rights reserved.
Table 1
Crystal data, data collection and reﬁnement statistics
Space group P21
Unit cell parameters
a (A˚) 51.7
b (A˚) 57.9
c (A˚) 88.8
a () 90.0
b () 102.5
c () 90.0
Molecules (a.u.) 2
Mosaicity () 0.26
Resolution range (A˚)a 25.00–1.94 [2.01–1.94]
Unique reﬂections 37 489
Average redundancy 3.1
Completeness (%) 99.7 [100]
Rsym (%) 5.0 [31.4]
I/r(I) 18.5 [3.9]
Reﬁnement range (A˚) 20.3–1.95
Non-hydrogen atoms 4492
Amino-acid residues 507
(S)-glutamate 2
Sulfate ions 7
Water molecules 398
Rwork (%)
b 19.9
Rfree (%)
c 26.9
R.m.s.d. bond lengths (A˚)/angles () 0.021/1.9
Residues in allowed regions of
Ramachandran plot (%)d
98.7
Average B-values (A˚2) for
protein/Glue/water/sulfate atoms
28.5/16.1/36.9/65.0
aThe values in brackets correspond to the outermost resolution shell.
bRwork ¼
P
h k lðjjF o;h k lj  jF c;h k ljjÞ=jF o;h k lj, where jFo, hk lj and jFc, h k lj
are the observed and calculated structure factor amplitudes.
cRfree is equivalent to the Rwork, but calculated with reﬂections omitted
from the reﬁnement process (5% of reﬂections omitted).
dThe Ramachandran plot was calculated according to [36].
eGlu denotes (S)-glutamate.
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cleavage site. The numbering corresponds to GluR5-2. The sequence
was veriﬁed by sequencing.
The GluR5 ligand-binding core expression construct was trans-
formed into the E. coli cell line Origami 2 (Novagen). Two liters of Hy-
per Broth (Athenaes, MD, USA) containing 30 lg/ml kanamycin and
12.5 lg/ml tetracycline were inoculated with an overnight culture and
grown to an OD600 of ca. 1.8 at 37 C, 120 rpm before induction with
isopropyl-b-D-thiogalactopyranoside (IPTG) to 250 lM. Protein was
expressed overnight at 25 C, 120 rpm shaking.
After cell harvesting and centrifugation, the protein was puriﬁed by
Ni2+ aﬃnity chromatography using Chelating Sepharose (Amersham
Pharmacia, Uppsala, Sweden) and eluted with a buﬀer containing
20 mM Tris–HCl, pH 7.5, 500 mM NaCl and 200 mM imidazole. Fol-
lowing dialysis against 100 volumes of buﬀer containing 20 mMNaOAc,
pH 5.5, 1 mM (S)-glutamate and 10 mM ethylenediaminetetraacetate
(EDTA), the His-tag was cleaved of by trypsin digestion. The protein
was applied to aMono-S cation exchange column (Amersham Pharma-
cia) in 20 mMNaOAc, pH 5.5, 1 mM (S)-glutamate and 10 mMEDTA,
and eluted with a gradient of 0–200 mMNaCl. A ﬁnal gel ﬁltration step
was done on a Superdex 75 column (Amersham Pharmacia).
2.2. Crystallization and data collection
For crystallization of the complex, a 5.2 mg/ml GluR5-S1S2 solution
(10 mM HEPES, pH 7.0, 30 mM NaCl and 1 mM EDTA) containing
20 mM (S)-glutamate was used, giving a protein to ligand ratio of
1:110. Crystals were obtained at 6 C by the hanging drop vapor diﬀu-
sion method. Drops of 1 + 1 ll protein and reservoir solutions were
applied; the reservoir solution consisting of 17% polyethylene glycol
(PEG) 4000, 0.1 M phosphate-citrate, pH 4.0 and 0.4 M lithium sul-
fate. Crystals were transferred through a cryo-protectant with 20%
glycerol in reservoir solution prior to ﬂash-cooling in liquid nitrogen.
The X-ray diﬀraction data were collected at cryogenic temperature
with wavelength of 0.8128 A˚ using a MAR CCD detector at beamline
X11 (DESY, Hamburg, Germany). The crystal diﬀracted to 1.94 A˚.
The HKL package (Denzo and Scalepack) [18] was used for autoindex-
ing and data processing; for statistics see Table 1.
2.3. Structure determination and reﬁnement
The GluR5-S1S2:(S)-glutamate structure was determined by the
molecular replacement method using CaspR [19]. The crystal structure
of GluR2-S1S2J in complex with (S)-glutamate (MolA, pdb code
1FTJ) was used as the input structure. A solution comprising two mol-
ecules was obtained. Automated model building was performed with
the program ARP/wARP [20], resulting in the tracing of 83% of the
residues. The missing residues were built manually using the program
O [21]. Reﬁnement of the structure was performed with the program
REFMAC 5 [22] as implemented in the CCP4 suite of programs
[23]. For statistics on reﬁnement, see Table 1.
2.4. Structure analysis and ﬁgure preparation
The HINGEFIND script [24] implemented in the program VMD
[25] was used to calculate the ligand-induced domain closure relative
to the apo GluR2-S1S2J structure (pdb code 1FTO, MolA). The
CCP4 program CONTACTS was used in the analysis of protein–
ligand and protein–protein interactions. The interface accessible sur-
face area was generated by the Protein–Protein Interaction Server
[26]. The programs Pymol [27] and Molscript [28] were employed in
the preparation of ﬁgures.
2.4.1. Protein data bank accession number. The atomic coordinates
and structure factors of GluR5-S1S2:(S)-glutamate have been depos-
ited with the RCSB Protein Data Bank under the Accession code
1YCJ.3. Results and discussion
3.1. The crystal structure of GluR5-S1S2
The structure of the ligand-binding core of GluR5 is shown in
Fig. 1. Two similar molecules (MolA andMolB) are observed in
the asymmetric unit of the crystal (with root mean square devi-
ation (r.m.s.d.) on 250Ca atomsof 0.57 A˚).All residues ofMolB(the S1 residues 430–544, a Gly-Thr linker and the S2 residues
667–805) were traced. The C-terminal residues Arg800-Pro805
of MolA could not be modelled.
As expected from sequence alignments, the structure of the
ligand-binding core of GluR5 is very similar to that of the
AMPA receptor GluR2 and structurally less related to the gly-
cine preferring NMDA receptor NR1 (Fig. 1). From a struc-
tural alignment of GluR5-S1S2 and GluR2-S1S2J it is evident
that the main overall diﬀerences are located to ﬁve surface
loops, especially in the vicinity of residues 449 and 711. Also,
variations are found next to Asn493, Thr730 and Gln747,
where deletions have occurred in GluR5, and at the N- and
C-terminal regions (see Fig. 2). Furthermore, the positions
of the a-helices from residues 774–787 (GluR5 numbering)
are slightly shifted.
3.2. Interactions of (S)-glutamate with GluR5-S1S2
(S)-glutamate binds in a very similar manner to the ligand-
binding cleft in both molecules. The interactions between li-
gand and protein include hydrogen bonds, ionic interactions
and van der Waals (vdW) interactions. The a-carboxylate
group interacts with Thr518 and Arg523 of D1, and with
Ser689 of D2 (Table 2 and Fig. 3). The a-ammonium group
forms a tetrahedral network of interactions with protein resi-
dues Pro516 and Thr518 of D1, and Glu738 of D2. The c-car-
boxylate is involved in hydrogen bonding to Ser689 and
Thr690. Four areas in both D1 (residues 489–490, 516–518,
Fig. 2. Comparison of the structures of GluR5-S1S2 and GluR2-S1S2J. (A) Structural alignment of GluR5-S1S2 and GluR2-S1S2J. Boxes
correspond to structurally conserved regions. The Gly-Thr linker is shaded grey. (B) Superimposition of the D1 Ca-atoms of the structures of GluR5-
S1S2 and GluR2-S1S2J. A Ca-trace of the two structures is shown in stereo, with GluR5-S1S2 coloured in green and GluR2-S1S2J in magenta. Every
10th residue of the GluR5-S1S2 structure is labeled. (S)-glutamate is shown in ball-and-stick.
Fig. 1. Ligand-binding cores of the three classes of iGluRs. Cartoon representations of the overall structures of the AMPA receptor GluR2-S1S2J
(MolB, pdb code 1FTJ; left ﬁgure), the kainate receptor GluR5-S1S2 (MolB; middle ﬁgure) and the NMDA receptor NR1-S1S2 (MolA, pdb code
1PB7; right ﬁgure). Domain D1 (primarily composed of S1 residues) is colored cyan and D2 (primarily composed of S2 residues) is colored brown.
GluR2-S1S2J and GluR5-S1S2 were crystallized in the presence of (S)-glutamate, whereas NR1 was crystallized in complex with (S)-glycine. The
ligands are shown in ball-and-stick representation.
1156 P. Naur et al. / FEBS Letters 579 (2005) 1154–1160523 and 764) and D2 (685, 687–691, 736–738 and 741) are in
vdW contact with (S)-glutamate (distances less than 5.5 A˚).
Overall, the ligand–protein interactions are very similar in
the GluR5-S1S2 and GluR2-S1S2J structures. Interestingly,
four water molecules are engaged in hydrogen bonding to
(S)-glutamate in the present structure in contrast to only three
in the GluR2-S1S2J structure. The additional water molecule
W6 is in hydrogen-bonding distance to the a-ammonium
group of (S)-glutamate.3.3. (S)-glutamate induces a larger domain closure in GluR5
than in GluR2
A D1–D2 domain closure of ca. 26 (25.7 in MolA and
26.4 in MolB) of the GluR5-S1S2 structure is observed rela-
tive to the apo structure of GluR2-S1S2J. Hence, the closure
is ca. 6 larger than that of the GluR2-S1S2J:(S)-glutamate
complex.
The distinct pharmacology of GluR5 has in a number of
cases been attributed to Ser741, which is unique among
Table 2
Interactions of (S)-glutamate with the ligand-binding core of GluR5-
S1S2 and GluR2-S1S2J, respectively
(S)-glutamate GluR5-S1S2 GluR2-S1S2Ja
MolA MolB MolA
a-Carboxylate oxygen 1
Thr518(480)b N 2.8 3.0 3.0
Thr518(480) Oc1 3.4 3.5 3.5
Arg523(485) Ng1 2.8 2.8 2.8
a-Carboxylate oxygen 2
Arg523(485) Ng1 3.4 3.5 3.4
Arg523(485) Ng2 2.8 2.7 2.9
Ser689(654) N 2.8 2.9 2.9
Ser689(654) Oc 3.4 3.3
a-Ammonium group
Pro516(478) O 2.8 2.7 2.7
Thr518(480) Oc1 2.9 3.0 3.0
Glu738(705) Oe1 2.9 2.9 2.7
Glu738(705) Oe2 3.3 3.3 3.2
W6 3.0 3.0
c-Carboxylate oxygen 1
Ser689(654) N 3.2 3.1 3.3
Thr690(655) N 3.1 3.1 3.2
Thr690(655) Oc1 3.4 3.4 3.5
W1c 2.6 2.8 3.1
c-Carboxylate oxygen 2
Thr690(655) Oc1 2.7 2.7 2.7
W2c 3.0 2.7 3.0
W5c 2.7 2.8 2.8
aMolecule A of the GluR2-S1S2J:(S)-glutamate complex was used
(pdb code 1FTJ).
bNumbers in parentheses refer to GluR2.
cNumbering of water molecules as in [15].
Potential hydrogen bonds/ionic interactions (in A˚) to ligands within
3.5 A˚ are tabulated.
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acting with (S)-glutamate, but stabilizes a highly coordinated
network of water molecules by the formation of a hydrogen
bond from Oc to W7 (MolA: 2.8 A˚), which is further hydro-
gen bonded to two other water molecules (W5: 2.7 A˚ and
W6: 2.6 A˚), see Fig. 3. W6 interacts directly with the a-
ammonium group of (S)-glutamate, whereas W5 is con-Fig. 3. Close-up views of the binding mode of (S)-glutamate in GluR5-S1S
glutamate are shown. The unique hydrogen-bonding network from Ser741 to
nitrogen atoms are blue, sulfur atoms are yellow and carbon atoms of prote
shown as red spheres.nected to the c-carboxylate Oe2 atom and forms additional
hydrogen bonds to Glu738 N (3.0 A˚) and W8 (2.8 A˚). Fur-
thermore, the latter water molecule forms contacts to Ser721
Oc and to W2, which again forms hydrogen bonds to the c-
carboxylate Oe2 atom of (S)-glutamate, Val685 N (3.0 A˚)
and Leu736 O (2.7 A˚).
Met708R2, the equivalent amino acid to Ser741, in GluR2
has been shown to exert an induced ﬁt depending on the struc-
ture of the bound agonist in order to optimize vdW interac-
tions [15]. Interestingly, the two water molecules W6 and W7
occupy the same space in the GluR5 complex, suggesting a
ﬂexibility in this region allowing accommodation of large sub-
stituents as, e.g., the tert-butyl group in the GluR5 selective
(S)-2-amino-3-(5-tert-butyl-3-hydroxy-4-isoxazolyl)propionate
[(S)-ATPA] in the partly hydrophobic and hydrophilic pocket.
The pocket is clearly larger in GluR5 as compared to that of
GluR2. Mutagenesis studies have shown that the selective
(S)-ATPA binding to GluR5 depends on both the small size
of Ser741 and the ability to form hydrogen bonds [29]. Also,
the agonist (S)-2-amino-3-(3-hydroxy-7,8-dihydro-6H-cyclo-
hepta[d]-4-isoxazolyl)propionate [(S)-4-AHCP] displays selec-
tivity for homomers of the low aﬃnity kainate receptor
subunit GluR5 over the AMPA receptors [31]. Homology
modelling of the ligand-binding core of GluR5 and docking
of (S)-4-AHCP to this model has shown that the binding site
is larger than in GluR2; thus allowing the accommodation of
larger and more bulky ligands [31]. This is in agreement with
the results presented here and also with other modelling stud-
ies, e.g. [32,33].
The domain closure is stabilized by formation of eight inter-
domain interactions between D1 and D2 (Glu441 Oe2-Ser721
Oc, Tyr444 OH-Thr740 Oc1, Tyr444 OH-Ser741 Oc, Lys488
Nf-Asp687 Od2, Gly490 N-Asp687 O, Asn499 Nd2-Asp687
Od2, Thr518 Oc1-Ser689 Oc and Thr518 Oc1-Glu738 Oe2)
of which the Tyr444-Ser741 and Lys488-Asp687 are novel
compared to the GluR2 complex. It is remarkable that
Ser741, besides its role in ligand stabilization, also plays a role
in forming an interdomain lock. The interaction between
Glu441 and Ser721 is similar to that observed between
Glu402R2 and Thr686R2 in GluR2-S1S2J [9]. However, in-
creased ﬂexibility of Glu441 is indicated in the present struc-
ture as two diﬀerent side-chain conformations are seen in
MolB.2 (MolA; shown in stereo). All protein residues within 5.5 A˚ of (S)-
the ligand is illustrated by dotted lines. Oxygen atoms are colored red,
in and ligand have been colored yellow and grey. Water molecules are
1158 P. Naur et al. / FEBS Letters 579 (2005) 1154–1160Multiple conformations have been observed for the
Asp651R2-Ser652R2 peptide bond in GluR2-S1S2J [9,10,15].
In GluR5-S1S2, the corresponding peptide bond (Arg686-
Asp687) adopts the ﬂipped conformation compared to that
of the GluR2-S1S2J apo structure whereas in the GluR2-
S1S2J:(S)-glutamate complex, this peptide bond apparently
can exist in both conformations. A correlation between peptide
ﬂip and domain closure has been suggested, as a large degree
of closure (e.g. 21 for (S)-AMPA) has been observed in con-
junction with a ﬂipped peptide bond, in contrast to less closed
structures (e.g. 12 in kainate).
Also, the residues Val685 and Leu735 diﬀer between GluR5
and GluR2 (Leu650R2 and Tyr702R2) and might be of impor-
tance for agonist binding and selectivity. In support of this,
Armstrong et al. [34] reported that mutation of Leu650R2 to
Thr in GluR2-S1S2J yields a receptor that responds more po-
tently and eﬃcaciously to the partial agonist kainate and less
to the full agonist AMPA compared to unmodiﬁed GluR2-
S1S2J. In GluR2, Tyr702R2 has been shown to be the determi-
nant of agonist selectivity between GluR1/R2 and GluR3/R4;
in the latter two receptors the corresponding residue is a Phe,
which results in the disappearance of an essential structural
water molecule [10]. However, this water molecule (W2) is still
present in the GluR5-S1S2 structure.
In summary, the smaller residues in GluR5 seem to allow
larger domain closures compared to that of GluR2, and this
may explain the functional selectivity of some agonists towards
GluR5. The true signiﬁcance of this ﬁnding has to wait for fur-
ther experiments, including the structure determination of theFig. 4. Dimers of GluR5-S1S2 (A) and GluR2-S1S2J (B) shown in stereo. Do
been superimposed and is colored using bright colours, while the other proto
stick. Residues involved in the dimerization interface in both GluR5 and Gl
792, 793), residues only involved in GluR5 dimerization are yellow (residues
dimerization are red (residues 519–522, 524, 525, 529–531, 693, 698, 762, 776
Thr linker is shown in green. The distance (in A˚) between linker residues (TGluR5-S1S2 apo form, which will provide a domain-closure
reference.
3.4. The GluR5-S1S2 dimer
The two molecules of GluR5-S1S2 form a dimer with buried
surface area of ca. 800 A˚2 per protomer. 24 Residues (532, 535,
669–672, 699–702, 754, 756–761, 783, 786–789 and 792–793)
contribute to the dimer interface, forming in total eight direct
hydrogen bonds as well as a potential salt-bridge and 10 water-
bridged interactions.
The GluR5-S1S2 dimer is novel compared to that of GluR2-
S1S2J as a diﬀerent arrangement of the two protomers is ob-
served (Fig. 4). Eleven (Asp669, Ser670, Ala671, Asp672,
Ser700, Thr701, Tyr702, Ser754, Gly756, Tyr757 and Gly758)
of the 24 residues at the GluR5-S1S2 interface are not involved
in GluR2-S1S2J dimer formation. Of these, six residues (resi-
dues 670, 671, 754, 756–758) are identical in GluR5 and GluR2.
Similarly, 16 of the 29 residues forming the dimer interface in
GluR2 are not engaged in GluR5 dimer interaction. Of the
16 residues, 69% (519–521, 524, 525, 529–531, 693, 698 and
762) are identical between GluR2 and GluR5. Interestingly,
the rate of desensitization in GluR2 mainly depends on the sta-
bility of the interface interactions between Leu483R2, Leu748R2
and Lys752R2 and between Ser729R2 and Asn754R2 (GluR2
numbering). Neither of these interactions is observed in the
GluR5 dimer. This is supported by the observation that
mutations of the position equivalent to Leu483R2 in the
GluR5-homologous kainate receptor GluR6 did not aﬀect the
desensitization properties, while desensitization is abolishedmain D1 of one protomer (right) of GluR5-S1S2 and GluR2-S1S2J has
mer is depicted in pale colours. The (S)-glutamate is shown in ball-and-
uR2 are coloured blue (residues 532, 535, 699, 759–761, 783, 786–789,
669–672, 700–702, 754, 756–758) and residues only involved in GluR2
, 779, 780, 784). Numbering is according to GluR5 sequence. The Gly-
hr to Thr) is indicated.
P. Naur et al. / FEBS Letters 579 (2005) 1154–1160 1159in GluR2 [35]. This supports the notion that the residue in-
volved in the stabilization in the GluR2 dimer interface is not
involved in the interface interaction in GluR5.
Residues involved in the dimerization interface in both
GluR5 and GluR2 are also observed (Fig. 4) but are forming
diﬀerent contacts. In total, 62% of the common interface res-
idues are identical between GluR5 and GluR2: Lys532,
Met535, Ile699, Asp760, Ser761, Leu783, Glu787 and
Gly789 (using GluR5 numbering), whereas the residues
Ile759(Leu in GluR2), Gln786(Asn) and Glu788(Gln) are
conservatively substituted. His792 and Met793 diﬀer from
those in GluR2 (Asp and Lys, respectively). The most buried
residues in the GluR5 interface are Leu783, Gln786, Glu787
and His792. The three corresponding residues in GluR2
(Leu751R2, Asn754R2 and Glu755R2) have also been shown
to be important for receptor dimerization and desensitization
[12]. In addition, mutation of Gln786 to Ser will partially
establish the non-desensitizing eﬀect of cyclothiazide on
GluR5.
Interestingly, two sulfate ions are present at the dimerization
interface; one connecting His792 (MolA) to Leu758 (MolB)
and vice versa at the second sulfate. These sites might be po-
tential binding sites for allosteric modulators.
In conclusion, the surprisingly diﬀerent dimer interface in
GluR5-S1S2 and GluR2-S1S2J suggests a diﬀerent coupling
between domain closure and channel opening. The dimer
topology, combined with the domain closure induced by (S)-
glutamate, leads to a separation of the residues connecting
the binding domain to the pore region of 41.9 A˚ compared
to 39.5 A˚ in GluR2 (Fig. 4). Finally, it is also possible that
the present structure represents a desensitized form of the
receptor. A fuller understanding of this phenomenon awaits
further structural and functional studies.
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